跳至主要内容
临床试验/ISRCTN98283094
ISRCTN98283094已完成未知

Randomised trial of two versus three doses of human papillomavirus (HPV) vaccine in India

International Agency for Research on Cancer (IARC) (France)0 个研究点目标入组 16,000 人开始时间: 2008年6月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
16,000

研究概览

简要总结

2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26652797 results 2018 Results article in http://www.ncbi.nlm.nih.gov/pubmed/29551226 early results 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34634254/ (added 12/10/2021)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Apparently healthy, ambulant, unmarried girls aged 10 - 18 years and with intact uterus
  • 2. Resident in the villages chosen for the study

排除标准

  • Girls with any severe and/or debilitating illness

研究者

发起方
International Agency for Research on Cancer (IARC) (France)

相似试验